A key U.S. Senate committee says that cannabis' current federal classification of schedule 1 blocks scientific research on its effects. But despite the seeming concern about the effect of state legalization, the panel's criticism of Schedule I's roadblocks to marijuana research provides more momentum to the effort to reclassify cannabis under federal law. This post from Forbes, ... Continue Reading